SEC Filing Summary: BeiGene, Ltd. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BeiGene, Ltd. on December 23, 2024. The registrant is incorporated in the Cayman Islands and its American Depositary Shares (ADSs) are listed on the Nasdaq Global Select Market. The report addresses a corporate event regarding the trading symbol of its securities.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the rebranding of the company's trading symbol on the Nasdaq Global Select Market:
- Current Ticker: BGNE
- New Ticker: ONC
- Effective Date: Trading under the new symbol will commence on January 2, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the administrative change of the ticker symbol.
Key Facts for Investor Verification
- Verify the ticker symbol change from BGNE to ONC on January 2, 2025, to ensure proper trade execution.
- Confirm that the underlying security remains the American Depositary Share representing 13 Ordinary Shares.
- Note that the ordinary shares continue to trade on The Stock Exchange of Hong Kong Limited under symbol 06160.